Angiogenesis in Cancers
Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many rep...
Gespeichert in:
| Format: | Online |
|---|---|
| Sprache: | Englisch |
| Veröffentlicht: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Schlagworte: | |
| Online-Zugang: | ONIX_20230405_9783036569161_238 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
| _version_ | 1869518814064934912 |
|---|---|
| collection | Directory of Open Access Books |
| description | Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many reports of associations between tumor inflammatory infiltration, progression and prognosis. New therapeutic approaches have been developed with the aim to control tumor progression through the targeting of different components of the tumor microenvironment. This reprint will be useful for anyone who wants to learn about cancer: professors and students at universities, scientists at research institutes, biotechnology, and pharmaceutical labs, and lawyers trying to understand the patent literature. |
| format | Online |
| id | doab-20.500.12854ir-98959 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-989592024-03-31T13:10:39Z Angiogenesis in Cancers Ribatti, Domenico RBP4 metastasis breast cancer angiogenesis endothelial dysfunction STAT3 VEGF endothelin-1 resveratrol gemcitabine endoglin ERKs microvessel growth lung cancer cancer anticancer DLBCL tumor microenvironment cell adhesion mediated drug resistance tumor progression VEGFR anti-angiogenesis anti-angiogenic agents immunosuppression immunotherapy immune-checkpoint inhibitors combination therapy tumor angiogenesis endothelium microenvironment multiple myeloma adhesion molecules immune-checkpoint inhibitor tumor-derived exosomes small extracellular vesicles feline mammary carcinoma VEGF-A VEGFR-1 VEGFR-2 non-invasive biomarkers selectins E-selectin uproleselan adrenal fetal cortex adrenocortical tumors adrenocortical carcinoma anti-angiogenic drugs bFGF anti-angiogenic therapy resistance vascular permeability drug delivery system microbeam radiation therapy (MRT) Chicken Chorioallantoic Membrane (CAM) U-87 Glioblastoma ginsenoside Rg3 response surface methodology optimisation epimer long pentraxin 3 FGF/FGFR system thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many reports of associations between tumor inflammatory infiltration, progression and prognosis. New therapeutic approaches have been developed with the aim to control tumor progression through the targeting of different components of the tumor microenvironment. This reprint will be useful for anyone who wants to learn about cancer: professors and students at universities, scientists at research institutes, biotechnology, and pharmaceutical labs, and lawyers trying to understand the patent literature. 2023-04-05T13:01:03Z 2023-04-05T13:01:03Z 2023 book ONIX_20230405_9783036569161_238 9783036569161 9783036569178 https://directory.doabooks.org/handle/20.500.12854/98959 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/7012 https://mdpi.com/books/pdfview/book/7012 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-6917-8 10.3390/books978-3-0365-6917-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036569161 9783036569178 274 Basel open access |
| spellingShingle | RBP4 metastasis breast cancer angiogenesis endothelial dysfunction STAT3 VEGF endothelin-1 resveratrol gemcitabine endoglin ERKs microvessel growth lung cancer cancer anticancer DLBCL tumor microenvironment cell adhesion mediated drug resistance tumor progression VEGFR anti-angiogenesis anti-angiogenic agents immunosuppression immunotherapy immune-checkpoint inhibitors combination therapy tumor angiogenesis endothelium microenvironment multiple myeloma adhesion molecules immune-checkpoint inhibitor tumor-derived exosomes small extracellular vesicles feline mammary carcinoma VEGF-A VEGFR-1 VEGFR-2 non-invasive biomarkers selectins E-selectin uproleselan adrenal fetal cortex adrenocortical tumors adrenocortical carcinoma anti-angiogenic drugs bFGF anti-angiogenic therapy resistance vascular permeability drug delivery system microbeam radiation therapy (MRT) Chicken Chorioallantoic Membrane (CAM) U-87 Glioblastoma ginsenoside Rg3 response surface methodology optimisation epimer long pentraxin 3 FGF/FGFR system thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Angiogenesis in Cancers |
| title | Angiogenesis in Cancers |
| title_full | Angiogenesis in Cancers |
| title_fullStr | Angiogenesis in Cancers |
| title_full_unstemmed | Angiogenesis in Cancers |
| title_short | Angiogenesis in Cancers |
| title_sort | angiogenesis in cancers |
| topic | RBP4 metastasis breast cancer angiogenesis endothelial dysfunction STAT3 VEGF endothelin-1 resveratrol gemcitabine endoglin ERKs microvessel growth lung cancer cancer anticancer DLBCL tumor microenvironment cell adhesion mediated drug resistance tumor progression VEGFR anti-angiogenesis anti-angiogenic agents immunosuppression immunotherapy immune-checkpoint inhibitors combination therapy tumor angiogenesis endothelium microenvironment multiple myeloma adhesion molecules immune-checkpoint inhibitor tumor-derived exosomes small extracellular vesicles feline mammary carcinoma VEGF-A VEGFR-1 VEGFR-2 non-invasive biomarkers selectins E-selectin uproleselan adrenal fetal cortex adrenocortical tumors adrenocortical carcinoma anti-angiogenic drugs bFGF anti-angiogenic therapy resistance vascular permeability drug delivery system microbeam radiation therapy (MRT) Chicken Chorioallantoic Membrane (CAM) U-87 Glioblastoma ginsenoside Rg3 response surface methodology optimisation epimer long pentraxin 3 FGF/FGFR system thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | RBP4 metastasis breast cancer angiogenesis endothelial dysfunction STAT3 VEGF endothelin-1 resveratrol gemcitabine endoglin ERKs microvessel growth lung cancer cancer anticancer DLBCL tumor microenvironment cell adhesion mediated drug resistance tumor progression VEGFR anti-angiogenesis anti-angiogenic agents immunosuppression immunotherapy immune-checkpoint inhibitors combination therapy tumor angiogenesis endothelium microenvironment multiple myeloma adhesion molecules immune-checkpoint inhibitor tumor-derived exosomes small extracellular vesicles feline mammary carcinoma VEGF-A VEGFR-1 VEGFR-2 non-invasive biomarkers selectins E-selectin uproleselan adrenal fetal cortex adrenocortical tumors adrenocortical carcinoma anti-angiogenic drugs bFGF anti-angiogenic therapy resistance vascular permeability drug delivery system microbeam radiation therapy (MRT) Chicken Chorioallantoic Membrane (CAM) U-87 Glioblastoma ginsenoside Rg3 response surface methodology optimisation epimer long pentraxin 3 FGF/FGFR system thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230405_9783036569161_238 |